Cargando…

Proteomic investigation reveals dominant alterations of neutrophil degranulation and mRNA translation pathways in patients with COVID-19

The altered molecular proteins and pathways in response to COVID-19 infection are still unclear. Here, we performed a comprehensive proteomics-based investigation of nasopharyngeal swab samples from patients with COVID-19 to study the host response by employing simple extraction strategies. Few of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Bankar, Renuka, Suvarna, Kruthi, Ghantasala, Saicharan, Banerjee, Arghya, Biswas, Deeptarup, Choudhury, Manisha, Palanivel, Viswanthram, Salkar, Akanksha, Verma, Ayushi, Singh, Avinash, Mukherjee, Amrita, Pai, Medha Gayathri J., Roy, Jyotirmoy, Srivastava, Alisha, Badaya, Apoorva, Agrawal, Sachee, Shrivastav, Om, Shastri, Jayanthi, Srivastava, Sanjeeva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857979/
https://www.ncbi.nlm.nih.gov/pubmed/33558857
http://dx.doi.org/10.1016/j.isci.2021.102135
Descripción
Sumario:The altered molecular proteins and pathways in response to COVID-19 infection are still unclear. Here, we performed a comprehensive proteomics-based investigation of nasopharyngeal swab samples from patients with COVID-19 to study the host response by employing simple extraction strategies. Few of the host proteins such as interleukin-6, L-lactate dehydrogenase, C-reactive protein, Ferritin, and aspartate aminotransferase were found to be upregulated only in COVID-19-positive patients using targeted multiple reaction monitoring studies. The most important pathways identified by enrichment analysis were neutrophil degranulation, interleukin-12 signaling pathways, and mRNA translation of proteins thus providing the detailed investigation of host response in COVID-19 infection. Thus, we conclude that mass spectrometry-detected host proteins have a potential for disease severity progression; however, suitable validation strategies should be deployed for the clinical translation. Furthermore, the in silico docking of potential drugs with host proteins involved in the interleukin-12 signaling pathway might aid in COVID-19 therapeutic interventions.